Monsanto announced that it has received an unsolicited purchase offer from Bayer AG. The offer is under consideration by Monsanto's board of directors. The companies are both major sellers of pesticides and of seeds for crops. Monsanto's market capitalisation on 18 May was $42.43 billion.
According to Dow Jones Business News via NASDAQ:
Folding Monsanto's world-leading seed franchise and its trademark Roundup herbicide business into Bayer would create a company with a combined $68 billion in annual sales, marketing products ranging from Aspirin pain-relief pills to crop genetics that enable plants to withstand bugs and weedkillers. The combination would sell about 28% of the world's pesticides and about 36% of U.S. corn seeds and 28% of soybean seeds, according to Morgan Stanley estimates.
Coverage:
related story:
Cartoonist Fired for Criticizing Big Agriculture
(Score: 0) by Anonymous Coward on Thursday May 19 2016, @10:29PM
After you eat a big meal with Monsanto's GMO food, you're gonna need some aspirin.
(Score: 2) by That_Dude on Friday May 20 2016, @12:31AM
And just who do you think they tested that aspirin formulation on??????
(Score: 0) by Anonymous Coward on Friday May 20 2016, @01:05AM
Go for the triple: McSanto's GMO hamburgers and aspirin chaser.